ResourceSeparations

Size Exclusion Chromatography Method Optimization using the European Pharmacopoeia for Insulin Fibrils

Size Exclusion Chromatography Method Optimization using the European Pharmacopoeia for Insulin Fibrils

4 Apr 2016

Insulin is a peptide hormone which plays a central role in metabolism. In its monomer form, insulin can partially misfold, causing a cascade of non-native cross assembly of beta-pleated sheets or amyloid-like fibrils. A common method for analyzing insulin HMWP is size exclusion chromatography (SEC). However, the method requires a lengthy 35 minute run time which is time prohibitive for any laboratory with many samples to run and data points to generate. This application shows the method transfer of the Ph. Eur. method from a traditional, 10µm hydrophilic silica 300 x 7.8mm column to a high performance, 1.8µm hydrophilic silica 150 x 4.6mm column.

Yarra Ultra-High Efficiency Aqueous GFC/SEC Columns

Phenomenex Inc

Starting with 3 µm ultra-pure silica, Yarra particles are densely bonded with a proprietary surface chemistry. Coupled with tight particle and pore size distribution as well as strict packing and QC specifications, Yarra GFC columns allow for the highest efficiencies and resolution possible. Yarra columns are offered in three phases (SEC-2000, 3000, and 4000), and are ideal for the separation of small to large proteins, as well as biological therapeutics and biosimilars.

(1)

Links

Tags

Size Exclusion Chromatography Method Optimization using the European Pharmacopoeia for Insulin Fibrils